Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...

Antibody-drug conjugates (ADCs) represent a powerful therapeutic modality for solid tumors and hematological malignancies. However, their development is often challenged by limited translational ...

Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...

This article is based on a poster originally authored by Fiona Leslie, Chloe Whiting, and Megan Webster. TGF-β1-mediated activation of fibroblasts, their transition to α-SMA-expressing myofibroblasts, ...

Standard bioassays often fall short when evaluating T cell engagers due to their diverse mechanisms of actions (MOAs) and functional complexity. To generate meaningful preclinical data, ...

BOSTON, Jan. 8, 2026 /PRNewswire/ -- Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of strategic investments to expand and ...

Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic Since 2006, when the U.S. FDA published a draft guidance on drug interaction studies, it has expected new ...

Angiogenesis plays a critical role in a wide range of biological processes, including wound healing, reproduction, and cancer. Scientists engaged in angiogenesis drug development research seek ways to ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, Jan. 8, 2026 /PRNewswire/ -- Perceptive Discovery, the preclinical and translational services division of ...